• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Nexalin Technology, Inc. - Common Stock (NQ:NXL)

    1.860 -0.170 (-8.37%)
    Delayed Quote Updated: 4:00 PM EDT, Oct 23, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 25,612
    Open 2.030
    Bid (Size) 1.890 (700)
    Ask (Size) 1.970 (100)
    Prev. Close 2.030
    Today's Range 1.860 - 2.070
    52wk Range 1.860 - 49.50
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Nexalin Technology Regains Compliance with Nasdaq Minimum Bid Price Requirement; Nasdaq Hearings Panel Grants Request for Continued Listing
    Company remains focused on its transition toward commercial revenue generation and the advancement of its U.S. clinical programs 
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    Friday's session: top gainers and losers ↗
    Via Chartmill

    Performance

    52-Week Range 96.2% below 52-week high
    1.860
    1.8652W Low 49.5052W High
    1 Week 26.8% below 1-week high
    1.861W Low 2.541W High

    Nexalin Technology, Inc. - Common Stock (NXL) traded between $1.86 and $49.50 over the past 52 weeks and last traded at $1.86, 96.2% below its 52-week high. Over the past week it ranged between $1.86 and $2.54.

    Past 12 Months
    -21.2%
    -61.3%
    -87.1%
    -85.4%
    -89.4%
    -95.8%
    1W -$0.50
    1M -$2.95
    3M -$12.58
    6M -$10.92
    YTD -$15.62
    1Y -$42.54

    NXL was -95.8% over the past year, -85.4% over six months, -89.4% year to date, -21.2% in the last week.

    12 Months vs Market
    NXL
    -95.8%
    DIA
    +11.6%
    SPY
    +13.1%
    QQQ
    +15.4%
    IWM
    +11.9%

    Over the past 12 months NXL returned -95.8% versus DIA (Dow) +11.6%, SPY (S&P 500) +13.1%, QQQ (Nasdaq 100) +15.4% and IWM (Russell 2000) +11.9%.

    Volume & Liquidity 0.03× 3-mo avg
    Today 25,612 3-mo avg 1.0M
    1W
    88.4K
    1M
    2.8M
    3M
    1.0M
    6M
    528.3K
    YTD
    335.3K
    1Y
    272.9K

    NXL most recently traded 25,612 shares against a 3-month average daily volume of 1.0M.

    More News

    Read More
    These stocks are moving in today's session ↗
    Via Chartmill
    Friday's session: gap up and gap down stocks ↗
    Via Chartmill
    Friday's pre-market session: top gainers and losers ↗
    Via Chartmill
    News headline image
    DarkHorse CEO Details AI Infrastructure Strategy as DRK Targets Sub-50 MW Compute Opportunity
    Via AB Newswire
    Topics Artificial Intelligence
    Which stocks are experiencing notable movement on Thursday? ↗
    Via Chartmill
    Thursday's session: gap up and gap down stocks ↗
    Via Chartmill
    News headline image
    Nexalin Technology Signs Definitive Exclusive Distribution and Local Manufacturing Agreement for Brazil and South America, Marking a Major Step in its Transition Toward Commercial Revenue Generation
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Nexalin Technology Taps Neuromodulation Commercial Executive Robert DiTota to Advise on its Global Commercialization Strategy
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Anixa Biosciences and Nexalin Technology Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
    From RedChip Companies, Inc. (Media Suite)
    Via ACCESS Newswire
    These stocks are moving in today's session ↗
    Via Chartmill
    Wondering what's happening in today's pre-market session? ↗
    Via Chartmill
    News headline image
    Nexalin Technology Announces Reverse Stock Split
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    Which stocks are moving before the opening bell on Tuesday? ↗
    Via Chartmill
    Curious about the stocks that are showing activity after the closing bell on Thursday? ↗
    Via Chartmill
    News headline image
    Nexalin Technology Announces that the Investigator of Its Brazilian Clinical Trial Received the Young Researcher Award at BRAIN 2026 for Research Evaluating the Company’s Proprietary DIFS™ Platform
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Nexalin Technology Announces Two Clinical Abstracts Accepted for Presentation at the 2026 NYC Neuromodulation Conference Highlighting Preliminary Clinical Results Across Anxiety, Depression, Insomnia and Quality of Life
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Nexalin Technology Reports Compelling Clinical Trial Results in Brazil to Support Product Launch. Trial Demonstrates 77.8% Anxiety Response Rate and Durable Benefits Across Depression, Insomnia and Quality of Life as Company Advances Brazilian Sales Plan.
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    Discover the top movers in Friday's pre-market session. ↗
    Via Chartmill
    News headline image
    Nexalin Technology Secures Key Neurostimulation Legislative Provision & Commends U.S. House-Passed Report Language Expanding Non-Invasive Deep Brain Neurostimulation Research at the Department of Veterans Affairs for Traumatic Brain Injury
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO™ Clarity and Nexalin NeuroCare™ Ahead of Planned FDA Pivotal Trial
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Nexalin Announces Peer-Reviewed Publication with Neuroimaging Data in Psychotherapy and Psychosomatics Highlighting Brain-Network Effects and Clinical Improvement in Chronic Insomnia
    From Nexalin Technology, Inc.
    Via GlobeNewswire
    News headline image
    Nexalin Technology Advances Pivotal Clinical Trial of HALO™ Clarity Toward Q2 2026 Enrollment
    From Nexalin Technology, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Nexalin Technology, Inc. - Common Stock publicly traded?
    Yes, Nexalin Technology, Inc. - Common Stock is publicly traded.
    What exchange does Nexalin Technology, Inc. - Common Stock trade on?
    Nexalin Technology, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Nexalin Technology, Inc. - Common Stock?
    The ticker symbol for Nexalin Technology, Inc. - Common Stock is NXL on the Nasdaq Stock Market
    What is the current price of Nexalin Technology, Inc. - Common Stock?
    The current price of Nexalin Technology, Inc. - Common Stock is 1.860
    When was Nexalin Technology, Inc. - Common Stock last traded?
    The last trade of Nexalin Technology, Inc. - Common Stock was at 10/23/26 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.